Live Breaking News & Updates on Keros Therapeutics Presents Clinical Trial|Page 1

Stay updated with breaking news from Keros therapeutics presents clinical trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Keros Therapeutics : Press release dated June 9, 2023 - Form 8-K

Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual. | June 9, 2023 ....

Justin Frantz , Jasbirs Seehra , Exchange Commission , Company Nasdaq , Keros Therapeutics Inc , Company Quarterly Report On Form , Inhibitor Program , European Hematology Association , Keros Therapeutics Presents Clinical Trial , Preclinical Study Results , Preclinical Data , Annual Congress , Keros Therapeutics , Chief Executive Officer , Ongoing Phase , Webcast Information , Private Securities Litigation Reform Act , Quarterly Report , Nc Stock Exchange , Press Release , 8th Kros Us4923271013 ,